Full Name
Dr. Prithviraj Bose MD
Job Title
Professor, Department of Leukemia
Company/Affiliation
MD Anderson Cancer Center
Speaker Bio
Dr. Prithviraj Bose is a professor in the Department of Leukemia at the MD Anderson Cancer Center in Houston, TX. After obtaining his medical degree from the University of Calcutta in Kolkata, India, where he attended the Calcutta Medical College, Dr. Bose completed an internship in internal medicine at a University of Washington affiliate in Spokane, WA, and residency at the Henry Ford Hospital in Detroit, MI, followed by a fellowship in hematology and oncology at the University of Oklahoma Health Sciences Center in Oklahoma City, OK. He then went on to join the hematology/oncology faculty at Virginia Commonwealth University (VCU) in Richmond, VA, where he was an assistant professor of medicine and a member of the NCI-designated VCU Massey Cancer Center.
At the Department of Leukemia at MDACC, which he joined in early 2015, Dr. Bose’s major clinical and research focus is on MPNs. He worked closely with Dr. Srdan Verstovsek, former Professor in the Department of Leukemia and chief of the section of MPNs. The two have authored numerous articles together in peer-reviewed journals and books. Dr. Bose is also heavily involved in clinical trial design for patients with MPN, and also in other areas of MPN research. He is leading a number of important therapeutic clinical trials in myelofibrosis, polycythemia vera and systemic mastocytosis. He speaks regularly on MPN topics at regional, national and international meetings, and co-chairs the annual US Focus meeting on MPNs and MDS.
Dr. Bose has published well over 400 peer-reviewed journal articles, book chapters and scientific meeting abstracts. His work has appeared in The New England Journal of Medicine, Cancer Cell, Journal of Clinical Oncology, Blood, Leukemia, Haematologica, Clinical Infectious Diseases, Williams’ Hematology and the MD Anderson Manual of Medical Oncology. Additionally, Dr. Bose regularly reviews articles for numerous hematology journals, including The Lancet Hematology, Blood, Leukemia, Blood Advances, American Journal of Hematology, British Journal of Haematology, Blood Cancer Journal, grant applications and abstracts for major international conferences such as ASH and EHA. He serves as an associate editor for Clinical Lymphoma Myeloma and Leukemia and as the MPN section editor for Current Hematologic Malignancy Reports.
At the Department of Leukemia at MDACC, which he joined in early 2015, Dr. Bose’s major clinical and research focus is on MPNs. He worked closely with Dr. Srdan Verstovsek, former Professor in the Department of Leukemia and chief of the section of MPNs. The two have authored numerous articles together in peer-reviewed journals and books. Dr. Bose is also heavily involved in clinical trial design for patients with MPN, and also in other areas of MPN research. He is leading a number of important therapeutic clinical trials in myelofibrosis, polycythemia vera and systemic mastocytosis. He speaks regularly on MPN topics at regional, national and international meetings, and co-chairs the annual US Focus meeting on MPNs and MDS.
Dr. Bose has published well over 400 peer-reviewed journal articles, book chapters and scientific meeting abstracts. His work has appeared in The New England Journal of Medicine, Cancer Cell, Journal of Clinical Oncology, Blood, Leukemia, Haematologica, Clinical Infectious Diseases, Williams’ Hematology and the MD Anderson Manual of Medical Oncology. Additionally, Dr. Bose regularly reviews articles for numerous hematology journals, including The Lancet Hematology, Blood, Leukemia, Blood Advances, American Journal of Hematology, British Journal of Haematology, Blood Cancer Journal, grant applications and abstracts for major international conferences such as ASH and EHA. He serves as an associate editor for Clinical Lymphoma Myeloma and Leukemia and as the MPN section editor for Current Hematologic Malignancy Reports.
Speaking At
